Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention

Clinical trial NCT03859245 · UNKNOWN

Trial details

NCT number: NCT03859245
Sponsor: Bristlecone Health, Inc.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetic Retinopathy (DR)Age-related Macular Degeneration (AMD)Mid-peripheral Drusen Formation Diabetic Macular Edema (DME)

Start date: 2019-02-23
Primary completion: 2020-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.